Efficacy and safety of fentanyl HCl iontophoretic transdermal system compared with morphine intravenous patient-controlled analgesia for postoperative pain management for patient subgroups
- PMID: 20186064
- DOI: 10.1097/EJA.0b013e3283349d82
Efficacy and safety of fentanyl HCl iontophoretic transdermal system compared with morphine intravenous patient-controlled analgesia for postoperative pain management for patient subgroups
Abstract
Background and objective: Inadequate postoperative pain control remains a problem for many patients undergoing surgery. This study presents subgroup analyses from a large, randomized, multicentre, European study comparing the efficacy and safety of the fentanyl HCl iontophoretic transdermal system and morphine intravenous patient-controlled analgesia for postoperative pain management.
Methods: The efficacy and safety of the fentanyl iontophoretic transdermal system and morphine intravenous patient-controlled analgesia were evaluated for patients divided by surgery type, sex, American Society of Anesthesiologists physical status and type of anaesthesia used during surgery. Efficacy measures included a patient global assessment of the method of pain control (a rating of 'good' or 'excellent' was considered as a success rating) and mean last pain intensity scores in the first 24 h. Discontinuation rates and the incidence of adverse events were also evaluated.
Results: Numerically similar percentages of patients in most subgroups reported success on the last patient global assessment in the first 24 h for both the fentanyl iontophoretic transdermal system and morphine intravenous patient-controlled analgesia. Similar percentages of investigators reported success ratings on the investigator global assessment at the last assessment for both treatment groups regardless of surgery type, except for the knee surgery subgroup (fentanyl iontophoretic transdermal system, 75%; morphine intravenous patient-controlled analgesia, 95%). Mean last pain intensity scores in the first 24 h after surgery were similar in all subgroups. Rates of patient withdrawals and the incidence of adverse events were generally similar between treatment groups in the patient subgroups.
Conclusion: The fentanyl iontophoretic transdermal system and morphine intravenous patient-controlled analgesia are comparably well tolerated and effective methods of pain control, regardless of sex, American Society of Anesthesiologists physical status or the type of anaesthesia used for surgery, and following most surgery types.
Similar articles
-
The safety and efficacy of fentanyl iontophoretic transdermal system compared with morphine intravenous patient-controlled analgesia for postoperative pain management: an analysis of pooled data from three randomized, active-controlled clinical studies.Anesth Analg. 2007 Nov;105(5):1428-36, table of contents. doi: 10.1213/01.ane.0000281913.28623.fd. Anesth Analg. 2007. PMID: 17959978
-
Efficacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery.Pain Med. 2007 Nov-Dec;8(8):657-68. doi: 10.1111/j.1526-4637.2006.00257.x. Pain Med. 2007. PMID: 18028044 Clinical Trial.
-
Fentanyl HCl iontophoretic transdermal system versus intravenous morphine pump after gynecologic surgery.Arch Gynecol Obstet. 2007 Sep;276(3):251-8. doi: 10.1007/s00404-007-0339-z. Epub 2007 Mar 22. Arch Gynecol Obstet. 2007. PMID: 17377800 Clinical Trial.
-
Current practices for postoperative pain management in Europe and the potential role of the fentanyl HCl iontophoretic transdermal system.Eur J Anaesthesiol. 2007 Apr;24(4):299-308. doi: 10.1017/S026502150600189X. Epub 2006 Dec 8. Eur J Anaesthesiol. 2007. PMID: 17156510 Review.
-
Fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain.Ann Pharmacother. 2006 Dec;40(12):2178-86. doi: 10.1345/aph.1H135. Ann Pharmacother. 2006. PMID: 17164395 Review.
Cited by
-
Fentanyl Iontophoretic Transdermal System.Hosp Pharm. 2016 Jan;51(1):71-82. doi: 10.1310/hpj5101-71. Epub 2016 Jan 1. Hosp Pharm. 2016. PMID: 38745711 Free PMC article. Review.
-
Topical Treatments for Localized Neuropathic Pain.Curr Pain Headache Rep. 2017 Mar;21(3):15. doi: 10.1007/s11916-017-0615-y. Curr Pain Headache Rep. 2017. PMID: 28271334 Free PMC article. Review.
-
Fentanyl Iontophoretic Transdermal System: A Review in Acute Postoperative Pain.Clin Drug Investig. 2016 Apr;36(4):321-30. doi: 10.1007/s40261-016-0387-x. Clin Drug Investig. 2016. PMID: 26968174 Review.
-
Transdermal Opioids for Cancer Pain Management.Rev Pain. 2010 Oct;4(2):8-13. doi: 10.1177/204946371000400203. Rev Pain. 2010. PMID: 26526770 Free PMC article.
-
Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plaster.Ther Clin Risk Manag. 2014 Apr 16;10:259-68. doi: 10.2147/TCRM.S58844. eCollection 2014. Ther Clin Risk Manag. 2014. PMID: 24790451 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources